1 - 10 of 23 articles
This content is only available as a PDF. © The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: email@example.com.
The Centers for Disease Control and Prevention, in collaboration with the partners and experts within the cancer community, is pleased to support this monograph, which summarizes the state of the scientific evidence and current research from experts on issues surrounding active surveillance and...
I teach. In fact, I teach law. One might guess that my training has led me to approach life’s challenges with a somewhat defined methodology. As happens to others, the discovery that I had prostate cancer pretty much took my breath away. After I became resigned to the disappointing news, I...
It is an axiom in medical education that case histories provide powerful opportunities to teach information gathering and application. Although a case history is most concerned with and centered on facts, these facts can be broadened and personalized by incorporating the patients’ views,...
Abstract This chapter addresses issues relevant to prostate cancer overdiagnosis. Factors promoting the overdiagnosis of prostate cancer are reviewed. First is the existence of a relatively large, silent reservoir of this disease, as can be seen by evaluating autopsy studies and histologic...
Abstract In the United States, prostate cancer is the most commonly diagnosed non–skin cancer and the second leading cause of cancer death. The American Cancer Society estimates that 241 740 American men will be diagnosed with the disease and 28 170 men will die of it in 2012. Prostate cancer...
Abstract Thirty years have witnessed dramatic changes in the manner in which we diagnose and manage prostate cancer. With prostate-specific antigen screening, there was a shift towards smaller, clinically localized tumors. Tumors are often multifocal and display phenotypic and molecular...
Abstract The diagnosis and detection of prostate cancer has undergone profound changes over the past three decades, due primarily to the development and widespread clinical use of prostate-specific antigen (PSA) testing. These changes have led to substantial differences in the prostate cancer...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.